Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
QIAGEN announces 2028 strategy for solid profitable growth
07:30am, Monday, 17'th Jun 2024
Hosts Capital Markets Day event in New York to outline strategy anchored by sharpened focus on growth pillars set to drive about 7% CER sales CAGR from 2024-2028 // Targeting at least 31% CER adjusted
QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
04:05pm, Thursday, 13'th Jun 2024
Latest QCI Interpret release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of results // New features include bulk variant assessment, flag
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth
04:05pm, Wednesday, 12'th Jun 2024
ESG commitments recognized as strategic business investments bringing value to stakeholders, including customers and employees // Environment: 15% reduction in Scope 1 and 2 emissions in 2023 through
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
04:05pm, Tuesday, 11'th Jun 2024
35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases, sexually transmitted and urine tract infecti
QIAGEN (QGEN) Unveils dPCR Tool, Enhances GeneGlobe Platform
10:05am, Monday, 10'th Jun 2024
QIAGEN (QGEN) launches the digital PCR Assay Design Tool for QIAcuity and expands the customization capabilities of its GeneGlobe research platform.
QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period
04:05pm, Thursday, 06'th Jun 2024
NeuMoDx 96 and NeuMoDx 288 Molecular Systems decision taken in light of challenging post-pandemic market development trends // Reaffirms Q2 2024 outlook, raises full-year 2024 outlook for adjusted dil
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe
04:05pm, Wednesday, 05'th Jun 2024
New QIAcuity digital PCR Custom Assay Design Tool for copy number variation analysis supports researchers' customization needs, complementing QIAGEN's existing pre-designed assays // GeneGlobe Design
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
09:21am, Wednesday, 05'th Jun 2024
QIAGEN's (QGEN) new QIAstat-Dx Gastrointestinal Panel 2 offers fast and accurate identification of up to 16 common gastrointestinal pathogens.
QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
09:26am, Monday, 03'rd Jun 2024
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care
02:00am, Monday, 03'rd Jun 2024
U.S. FDA clears QIAstat-Dx Gastrointestinal Panel 2 for use in clinical settings // New panel offers fast and accurate identification of up to 16 common gastrointestinal pathogens // Generates results
QIAGEN (QGEN) Develops Test for Research and CDx Application
10:41am, Friday, 31'st May 2024
QIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid tumor types, including ovarian cancer, and improve decentralized testing capabilities.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN's QIAseq xHYB technology, QIAGEN Digitial Insight solutions, and Myriad's proprietary, FDA-approved MyC
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
04:05pm, Wednesday, 29'th May 2024
QIAseq Multimodal DNA/RNA Lib Kit enables streamlined DNA and RNA library preparation for next-generation sequencing from a single sample // New kit advances precision medicine by facilitating multiom
Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue?
12:35pm, Wednesday, 29'th May 2024
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
Lab Instrument Industry Update - New Commercial Entrants
09:17am, Thursday, 23'rd May 2024
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h
